Compounds > yohimbine
Page last updated: 2024-08-20

yohimbine and Diabetic Neuropathies

yohimbine has been researched along with Diabetic Neuropathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, B; Lu, Y; Zhong, J1
Christoph, T; De Vry, J; Schröder, W; Tallarida, RJ; Tzschentke, TM1
Marshall, PG; Morales, A; Surridge, DH1
Christensen, NJ; Cryer, PE; Dejgaard, A; Hilsted, J; Liggett, SB1
Barbe, P; Berlan, M; Estan, L; Guimbaud, R; Louvet, JP; Montastruc, JL; Senard, JM; Tran, MA1
Abrahm, DR; Hollingsworth, PJ; Jim, L; Smith, CB; Sobotka, PA; Vinik, AI; Zucker, LB1

Other Studies

6 other study(ies) available for yohimbine and Diabetic Neuropathies

ArticleYear
The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
    Biological & pharmaceutical bulletin, 2017, Sep-01, Volume: 40, Issue:9

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glutamic Acid; Hyperalgesia; Inflammation; Interleukin-1beta; Male; Microglia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha; Yohimbine

2017
Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 347, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Data Interpretation, Statistical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Hot Temperature; Hyperalgesia; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Pain Measurement; Phenols; Receptors, Opioid, mu; Spinal Cord; Tapentadol; Yohimbine

2013
Yohimbine for treatment of impotence in diabetes.
    The New England journal of medicine, 1981, Nov-12, Volume: 305, Issue:20

    Topics: Diabetes Complications; Diabetic Neuropathies; Erectile Dysfunction; Humans; Male; Paresthesia; Yohimbine

1981
Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity.
    Scandinavian journal of clinical and laboratory investigation, 1991, Volume: 51, Issue:8

    Topics: Adult; Cell Membrane; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Epinephrine; Humans; Isoproterenol; Leukocytes, Mononuclear; Middle Aged; Pindolol; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine

1991
Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Blood Platelets; Brimonidine Tartrate; Cell Membrane; Diabetes Mellitus; Diabetic Neuropathies; Female; Glycated Hemoglobin; Humans; Hypotension, Orthostatic; Kinetics; Male; Middle Aged; Pressoreceptors; Quinoxalines; Receptors, Adrenergic, alpha; Yohimbine

1990
Decreased alpha 2-adrenergic receptors on platelet membranes from diabetic patients with autonomic neuropathy and orthostatic hypotension.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:4

    Topics: Adult; Aged; Autonomic Nervous System Diseases; Blood Platelets; Catecholamines; Clonidine; Diabetic Neuropathies; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Receptors, Adrenergic, alpha; Renin; Yohimbine

1986